Amgen news from FierceHealthcare
NewsAt critical stage, lobbyist spending may play key role
Depending on how you look at politics, this may or may not be a bad thing, but the fact remains: the five Senators who will run the floor debate on the reform bill have enjoyed some very substantial Read more...
Will 2009 be Consolidation Year for pharma?
With the giant union between Pfizer and Wyeth en route to being consummated, analysts are now speculating about other major mergers are to follow. Several think this could be the Year of Read more...
FDA demands new labels for Amgen anemia drugs
The FDA has demanded that drugmaker Amgen change the labels for its top-selling anemia drugs in a way which could further limit their use in treating cancer patients. In making the order, the FDA Read more...
| Press ReleasesNovo Nordisk, Roche, Amgen Score Top Marks in 2011 CenterWatch Global Site SurveyBOSTON--(BUSINESS WIRE)-- A new CenterWatch survey released today shows drug sponsors have continued to improve their relationships with investigative sites by focusing on strategies to improve site Read more >> TESARO Enters into Exclusive License Agreement with Amgen to Acquire Rights to Anaplastic Lymphoma Kinase (ALK) ProgramTESARO will be responsible for worldwide development and commercialization Amgen’s oral, small molecule ALK inhibitors are highly potent and selective, and possess desirable pharmaceutical properties Read more >> Three Innovative Ideas Receive $10,000 Prizes in Patients | Choices | Empowerment CompetitionTHOUSAND OAKS, Calif. and WASHINGTON, Dec. 8, 2010 /PRNewswire/ -- The Amgen Foundation and Ashoka's Changemakers today announced three winners for the Patients | Choices | Empowerment competition. Read more >> Amgen’s Prolia Has the Potential to Steal a Prominent Share of the Osteoporosis MarketMajestic Research Study Indicates Physicians Are Enthusiastic about Prolia’s Infrequent Dosing Regimen, but Have Concerns about the High Cost of Therapy NEW YORK--(BUSINESS WIRE)-- A study published Read more >> Amedisys, Inc. Named One of FORTUNE’s “100 Fastest-Growing Companies”In its third appearance on the list, Amedisys moves up 33 spots to #47 from #80 NEW YORK--(BUSINESS WIRE)-- FORTUNE announced Thursday that Amedisys, Inc. has been ranked number 47 on the 2010 “100 Read more >> |
